Monographie - Amphotericin B lipid complex

Poslední aktualizace :
19/11/2024

Amphotericin B lipid complex

Chemický vzorec

Obchodní název

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Abelcet

äpanÏlsko, Argentina, Austrálie, Belgie, BrazÌlie, Dánsko, Finsko, Francie, Irsko, Itálie, Kanada, Lucembursko, Malajsie, MaÔarsko, Mexiko, NÏmecko, Nizozemsko, Norsko, Peru, Portugalsko, Rakousko, Rumunsko, Švédsko, USA, Velká Británie, ÿecko

Odkazy : Amphotericin B lipid complex

	typ	uveřejnění
1510	kniha	AHFS Formulary service 2000 Bethesda - 3546 p
2247	noviny	Chan P, Heatherly K, Kupiec T.C, Trissel L.A. Compatibility of caspofungin acetate injection with other drugs during simulated Y-site coadministration. Int J Pharm Compound 2008 ; 12, 3: 276-278.
2262	noviny	Brammer MK, Chan P, Heatherly K, Trusley C, Kupiec TC, Trissel LA, Psathas PA, Gilmor T, Schaufelberger D. Compatibility of doripenem with other drugs during simulated Y-site administratioN Am J Health-Syst Pharm 2008 ; 65: 1261-1265.
3254	noviny	Housman S.T, Tessier P.R, Nicolau D.P, Kuti J.L. Physical compatibility of telavancin hydrochloride with select i.v. drugs during simulated Y-site administration Am J Health-Syst Pharm 2011 ; 68: 2265-2270.
3332	Laboratoř	Tigecycline (Tigacyl®) - Summary of Product characteristics Pfizer 2012
3644	Laboratoř	Calcium gluconate® - Summary of Product Characteristics Hameln Pharmaceuticals 2010
3828	plakát	Thabit A.K, Hamada Y, Nicolau D.P. Ceftozolane/tazobactam physical compatibility during simulated Y-site administration. ASHP Midyear 2015
3829	plakát	So W, Kim L, Thabit A.K, Nicolau D.P, Kuti J.L. Compatibility of isavunazonium sulfate during simulated Y-site administration. ASHP Midyear 2015
4055	noviny	Monogue M, Almarzoky Abuhussain S, Kuti J, Nicolau D. Physical compatibility of fosfomycin for injection with select i.v. drugs during simulated Y-site administration. Am J Health-Syst Pharm 2018 , 75, 1:36-44

Mentions Légales